Muzzey Dale

SEC source: 0001922964-26-000010 · wk-form4_1776284411.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 326,310

F1 · shares: Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on April 14, 2026.

SEC source: 0001922964-26-000008 · wk-form4_1774297381.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 327,256

F1 · shares: Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 20, 2026.

SEC source: 0001922964-26-000006 · wk-form4_1773695160.xml · nonDerivative · entry 5

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 329,275

F3 · shares: Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of the Issuer's Common Stock on March 13, 2026.

SEC source: 0001922964-26-000006 · wk-form4_1773695160.xml · nonDerivative · entry 4

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 341,224

F2 · shares: Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026.

SEC source: 0001922964-26-000006 · wk-form4_1773695160.xml · nonDerivative · entry 3

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 346,007

F2 · shares: Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026.

SEC source: 0001922964-26-000006 · wk-form4_1773695160.xml · nonDerivative · entry 2

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 354,295

F2 · shares: Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026.

SEC source: 0001922964-26-000006 · wk-form4_1773695160.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 367,074

F1 · shares: Consists of time-based restricted stock units granted pursuant to the Issuer's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001922964-26-000004 · wk-form4_1770157800.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 193,878

F1 · shares: Consists of performance-based restricted stock units (PSUs) initially granted on March 15, 2023, subject to accomplishment of pre-determined performance metrics. On February 2, 2026, the Compensation and Human Capital Committee of the Company's Board of Directors determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock and vests on March 15, 2026.

SEC source: 0001922964-26-000002 · wk-form4_1767388657.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 170,181

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on December 31, 2025.

SEC source: 0001922964-25-000004 · wk-form4_1744748070.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 170,599

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on April 14, 2025.

SEC source: 0001628280-25-014726 · wk-form4_1742933802.xml · nonDerivative · entry 4

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 171,541

F4 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2025.

SEC source: 0001628280-25-014726 · wk-form4_1742933802.xml · nonDerivative · entry 3

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 172,341

F3 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2025.

SEC source: 0001628280-25-014726 · wk-form4_1742933802.xml · nonDerivative · entry 2

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 172,886

F2 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 21, 2025.

SEC source: 0001628280-25-014726 · wk-form4_1742933802.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 178,220

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 21, 2025.

SEC source: 0001628280-25-013149 · wk-form4_1742242790.xml · nonDerivative · entry 3

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 180,231

F2 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 14, 2025.

SEC source: 0001628280-25-013149 · wk-form4_1742242790.xml · nonDerivative · entry 2

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 184,995

F2 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 14, 2025.

SEC source: 0001628280-25-013149 · wk-form4_1742242790.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 193,539

F1 · shares: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001628280-25-010137 · wk-form4_1741134685.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 117,766

F1 · shares: Consists of performance-based restricted stock units (PSUs) initially granted on March 22, 2022, subject to accomplishment of pre-determined performance metrics. On February 7, 2025, the Compensation and Human Capital Committee of the Company's Board of Directors determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock and vests on March 22, 2025.

SEC source: 0001922964-25-000002 · wk-form4_1735853189.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,144

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on December 31, 2024.

SEC source: 0001922964-24-000008 · wk-form4_1728592385.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,561

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 9, 2024.

SEC source: 0001922964-24-000006 · wk-form4_1726171753.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,013

SEC source: 0001922964-24-000004 · wk-form4_1713212823.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,113

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on April 12, 2024.

SEC source: 0001628280-24-012916 · wk-form4_1711398666.xml · nonDerivative · entry 3

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,053

F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024.

SEC source: 0001628280-24-012916 · wk-form4_1711398666.xml · nonDerivative · entry 2

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,614

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024.

SEC source: 0001628280-24-012916 · wk-form4_1711398666.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,996

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024.

SEC source: 0001628280-24-011682 · wk-form4_1710794714.xml · nonDerivative · entry 2

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,401

F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 15, 2024.

SEC source: 0001628280-24-011682 · wk-form4_1710794714.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 116,723

F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001922964-24-000002 · wk-form4_1704235912.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,473

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on December 29, 2023.

SEC source: 0001922964-23-000008 · wk-form4_1696968933.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,776

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 9, 2023.

SEC source: 0001922964-23-000006 · wk-form4_1695845879.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,084

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 26, 2023.

SEC source: 0001922964-23-000003 · wf-form4_168177002190556.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,217

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on April 14, 2023.

SEC source: 0001628280-23-009264 · wf-form4_167994889776174.xml · nonDerivative · entry 2

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,855

F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2023.

SEC source: 0001628280-23-009264 · wf-form4_167994889776174.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,400

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2023.

SEC source: 0001628280-23-009052 · wf-form4_167960335731267.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,772

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2023.

SEC source: 0001628280-23-008320 · wf-form4_167899860209122.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,171

F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001922964-23-000001 · wf-form4_167287373358897.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,712

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on December 30, 2022.

SEC source: 0001628280-22-026254 · wf-form4_166552056246727.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,014

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 7, 2022.

SEC source: 0001628280-22-025564 · wf-form4_166431067555459.xml · nonDerivative · entry 2

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,323

F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 26, 2022.

SEC source: 0001628280-22-025564 · wf-form4_166431067555459.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,456

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 23, 2022.

SEC source: 0001922964-22-000004 · edgardoc.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,801

F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date.